Q3 2021 13F Holders as of 9/30/2021
-
Type / Class
-
Equity / Common Stock, par value $0.00001 per share
-
Shares outstanding
-
96M
-
Number of holders
-
59
-
Total 13F shares, excl. options
-
17.4M
-
Shares change
-
+1.62M
-
Total reported value, excl. options
-
$211M
-
Value change
-
+$20.6M
-
Put/Call ratio
-
0.27
-
Number of buys
-
29
-
Number of sells
-
-26
-
Price
-
$12.16
Significant Holders of Cabaletta Bio, Inc. - Common Stock, par value $0.00001 per share (CABA) as of Q3 2021
75 filings reported holding CABA - Cabaletta Bio, Inc. - Common Stock, par value $0.00001 per share as of Q3 2021.
Cabaletta Bio, Inc. - Common Stock, par value $0.00001 per share (CABA) has 59 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 17.4M shares
of 96M outstanding shares and own 18.1% of the company stock.
Largest 10 shareholders include ADAGE CAPITAL PARTNERS GP, L.L.C. (3.04M shares), 5AM Venture Management, LLC (2.36M shares), Cormorant Asset Management, LP (1.61M shares), BOXER CAPITAL, LLC (1.6M shares), Ikarian Capital, LLC (1.19M shares), Point72 Asset Management, L.P. (900K shares), VANGUARD GROUP INC (731K shares), Redmile Group, LLC (696K shares), BAKER BROS. ADVISORS LP (662K shares), and CITADEL ADVISORS LLC (559K shares).
This table shows the top 59 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.